Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era

Ayman Elbadawi; Dhruv Mahtta; Islam Y. Elgendy; Marwan Saad; Chayakrit Krittanawong; Ravi S. Hira; Mohamed Omer; Gbolahan O. Ogunbayo; Kirk Garratt; Sunil V. Rao; Hani Jneid

doi:10.1016/j.jcin.2020.07.004

Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era

Ayman Elbadawi
, Dhruv Mahtta
, Islam Y. Elgendy
, Marwan Saad
, Chayakrit Krittanawong
, Ravi S. Hira
, Mohamed Omer
, Gbolahan O. Ogunbayo
, Kirk Garratt
, Sunil V. Rao
, Hani Jneid

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	2312-2314
Number of pages	3
Journal	JACC: Cardiovascular Interventions
Volume	13
Issue number	19
DOIs	https://doi.org/10.1016/j.jcin.2020.07.004
State	Published - Oct 12 2020

Funding

Dr. Garratt has received honoraria for serving on clinical events adjudication committees from Abbott Vascular and Jarvik Heart; and is a cofounder of and holds an equity position in LifeCuff Technologies, Inc. Dr. Rao has received research funding to his institution from Bayer, Shockwave Medical, and Svelte Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. †Drs. Elbadawi and Mahtta contributed equally to this work.

Funders
LifeCuff Technologies, Inc.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jcin.2020.07.004

Cite this

@article{b69db995d8f84f2a8b11c9a8ce7575be,

title = "Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era",

author = "Ayman Elbadawi and Dhruv Mahtta and Elgendy, \{Islam Y.\} and Marwan Saad and Chayakrit Krittanawong and Hira, \{Ravi S.\} and Mohamed Omer and Ogunbayo, \{Gbolahan O.\} and Kirk Garratt and Rao, \{Sunil V.\} and Hani Jneid",

year = "2020",

month = oct,

day = "12",

doi = "10.1016/j.jcin.2020.07.004",

language = "English",

volume = "13",

pages = "2312--2314",

number = "19",

}

TY - JOUR

T1 - Trends and Outcomes of Fibrinolytic Therapy for STEMI

T2 - Insights and Reflections in the COVID-19 Era

AU - Elbadawi, Ayman

AU - Mahtta, Dhruv

AU - Elgendy, Islam Y.

AU - Saad, Marwan

AU - Krittanawong, Chayakrit

AU - Hira, Ravi S.

AU - Omer, Mohamed

AU - Ogunbayo, Gbolahan O.

AU - Garratt, Kirk

AU - Rao, Sunil V.

AU - Jneid, Hani

PY - 2020/10/12

Y1 - 2020/10/12

UR - https://www.scopus.com/pages/publications/85091697525

UR - https://www.scopus.com/pages/publications/85091697525#tab=citedBy

U2 - 10.1016/j.jcin.2020.07.004

DO - 10.1016/j.jcin.2020.07.004

M3 - Letter

C2 - 33032721

AN - SCOPUS:85091697525

SN - 1936-8798

VL - 13

SP - 2312

EP - 2314

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 19

ER -

Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this